$NCSM

Grewal Gurinder sold (to issuer) 20,919 shares of NCSM

Grewal Gurinder sold (to issuer) 20,919 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Grewal Gurinder
Published Sep 1, 2026, 1:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
high confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The sale is a routine insider transaction with limited material impact on the stock.

02

Market read

Minor insider sell; unlikely to move the market.

03

What to watch

Potential upcoming corporate actions or dilution that prompted the director to exit.

Relevance 4/10Novelty 4/10Timing: same day filing

Background

SEC Form 4 filing discloses insider transactions; directors often sell for liquidity or tax planning.

Company-level read

Ticker impact

$NCSMNeutralHigh confidence
Context

Director Gurinder Grewal sold 20,919 shares of NCS Multistage Holdings, reducing his stake to zero.

Expected impact

No significant move expected.

Evidence & confidence

The transaction size is modest for a director and no price was disclosed, indicating limited market relevance.

Market effects

None

None

None

Counterpoint

The sell could signal insider concern, but lack of price data makes it speculative.

Key entities

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

  • Grewal Gurinder

    Director and insider who sold the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).